| Name | Ronidazole |
| Description | Ronidazole (Ronidazol) is an antiprotozoal and antimicrobial agent used mainly in veterinary practice. |
| In vitro | In cats, Ronidazole (30 or 50 mg/kg) is effective in treating fetal infections caused by Tritrichomonas. |
| In vivo | Ronidazole exhibits antiprotozoal activity. In vitro, Ronidazole (>0.1μg/ml) is capable of killing Tritrichomonas. |
| Storage | keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 250 mg/mL (1249.06 mM), Sonication is recommended. H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (9.99 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble)
|
| Keywords | veterinary | Tritrichomonas foetus,?infection,?histomoniasis | swine | Ronidazole | Parasite | nitroimidazole | Inhibitor | inhibit | dysentery | Bacterial | anti-microbial | Antibiotic |
| Inhibitors Related | Neomycin sulfate | Adipic dihydrazide | Levulinic acid | D(+)-Raffinose pentahydrate | Sulfamethoxazole sodium | Terbinafine hydrochloride | Hydroxychloroquine | 2-Amino-2-methyl-1-propanol | Fenpyroximate | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Anti-Parasitic Compound Library | Bioactive Compound Library | Antibiotics Library | NO PAINS Compound Library | Anti-Bacterial Compound Library | Orally Active Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Anti-Infection Compound Library | Anti-Gram-Positive Bacterial Library | Human Metabolite Library |